Evidence map›Paper›PMID 33339830›Full record

ArticleScientific data2020

Obstacles to the reuse of study metadata in ClinicalTrials.gov.

Laura Miron, Rafael S Gonçalves, Mark A Musen

Abstract read
In one paragraph

Article in Scientific data, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Landscape analysis of oncology nutrition research among patients being treated for cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  9. Article
  10. Patient Enrollment to Industry-Sponsored Versus Federally-Sponsored Cancer Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  11. Article
  12. Article
  13. Linking Cancer Clinical Trials to their Result Publications.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura MironStanford Center for Biomedical Informatics Research, Stanford University School of Medicine, 1265 Welch Rd, Stanford, CA, 94305, USA. lmiron@stanford.edu.ORCID 0000-0001-7016-9731
Rafael S GonçalvesStanford Center for Biomedical Informatics Research, Stanford University School of Medicine, 1265 Welch Rd, Stanford, CA, 94305, USA.ORCID 0000-0003-1255-0125
Mark A MusenStanford Center for Biomedical Informatics Research, Stanford University School of Medicine, 1265 Welch Rd, Stanford, CA, 94305, USA.ORCID 0000-0003-3325-793X

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
TrainingU54AI117925 · NIAID · STANFORD UNIVERSITY · PI MUSEN, MARK A · 2014 to 2018
$12.9M
American Heart Association (American Heart Association, Inc.) 18IDHP34660267Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) AI117925Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) GM21724NCATS NIH HHS UL1 TR003142NIAID NIH HHS U54 AI117925
6 · The paper itself

Abstract

Metadata that are structured using principled schemas and that use terms from ontologies are essential to making biomedical data findable and reusable for downstream analyses. The largest source of metadata that describes the experimental protocol, funding, and scientific leadership of clinical studies is ClinicalTrials.gov. We evaluated whether values in 302,091 trial records adhere to expected data types and use terms from biomedical ontologies, whether records contain fields required by government regulations, and whether structured elements could replace free-text elements. Contact information, outcome measures, and study design are frequently missing or underspecified. Important fields for search, such as condition and intervention, are not restricted to ontologies, and almost half of the conditions are not denoted by MeSH terms, as recommended. Eligibility criteria are stored as semi-structured free text. Enforcing the presence of all required elements, requiring values for certain fields to be drawn from ontologies, and creating a structured eligibility criteria element would improve the reusability of data from ClinicalTrials.gov in systematic reviews, metanalyses, and matching of eligible patients to trials.

Indexed as

Clinical Trials as TopicDatabases, FactualMetadataDatasets as TopicResearch Design

Identifiers

PMID33339830
PMCPMC7749162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.